BGP-15, a PARP-inhibitor, prevents imatinib-induced cardiotoxicity by activating Akt and suppressing JNK and p38 MAP kinases

Author: Sarszegi Zsolt  

Publisher: Springer Publishing Company

ISSN: 0300-8177

Source: Molecular and Cellular Biochemistry, Vol.365, Iss.1-2, 2012-06, pp. : 129-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract